Supporting our findings, the analysis of these TGCA gene expression dataset revealed that ID2 should be considered as an unfavourable prognostic gene (Fig. 7A) whereas ETS2 as a favourable prognostic gene for patients with glioma (Fig. 7B). This evidence concerns the gene ETS2 and central nervous system cancer.